HR6171-119

Introduced

To amend the Patient Protection and Affordable Care Act to establish an out-of-pocket limit on spending for prescription drugs.

119th Congress Introduced Nov 20, 2025

Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.

Summary

What This Bill Does

Caps annual out-of-pocket prescription drug cost sharing in ACA health plans beginning in 2027.

Who Benefits and How

Patients in ACA plans gain a federal limit on annual prescription drug cost sharing, reducing exposure to high drug out-of-pocket costs.

Who Bears the Burden and How

Health plan issuers must absorb or redesign benefits around the new prescription drug cost-sharing cap.

Key Provisions

  • Creates a $2,000 self-only annual prescription drug cost-sharing cap for 2027, indexed thereafter.
  • Sets the non-self-only cap at twice the self-only amount.
  • Applies the cap through ACA essential health benefit and cost-sharing provisions.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers.

At a Glance

What This Bill Does

Caps annual out-of-pocket prescription drug cost sharing in ACA health plans beginning in 2027.

Key Policy Areas

Healthcare, Finance, Government Operations

Primary Purpose

Caps annual out-of-pocket prescription drug cost sharing in ACA health plans beginning in 2027.

Policy Domains

Healthcare Finance Government Operations

Main Provisions

Identified Gains
Contextual inference, no direct clause citation
  • Patients enrolled in ACA plans who use prescription drugs
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Identified Costs
Contextual inference, no direct clause citation
  • ACA health plan issuers
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih

Contextual inference, no direct clause citation

Legislative Progress

Introduced
Introduced Committee Passed
Nov 20, 2025

Mr. Auchincloss introduced the following bill; which was referred to …

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
1 mention across 1 clause
+1 positive

Patients enrolled in ACA plans who use prescription drugs

Financial Services
1 mention across 1 clause
-1 negative

ACA health plan issuers

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Finance Government Operations

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology